H1OL34 logo

Hologic BOVESPA:H1OL34 Stock Report

Last Price

R$447.04

Market Cap

R$107.1b

7D

0%

1Y

32.5%

Updated

26 Oct, 2024

Data

Company Financials +

Hologic, Inc.

BOVESPA:H1OL34 Stock Report

Market Cap: R$107.1b

H1OL34 Stock Overview

Develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. More details

H1OL34 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 30.4% below our estimate of its fair value

Earnings grew by 43.2% over the past year

Risk Analysis

Shares are highly illiquid


Hologic, Inc. Competitors

Rede D'Or São Luiz

BOVESPA:RDOR3

R$66.1b

Olympus

TSE:7733

JP¥2.8t

Zimmer Biomet Holdings

NYSE:ZBH

US$22.4b

Fisher & Paykel Healthcare

NZSE:FPH

NZ$22.0b

Price History & Performance

Summary of all time highs, changes and price drops for Hologic
Historical stock prices
Current Share PriceUS$447.04
52 Week HighUS$447.04
52 Week LowUS$353.50
Beta0.98
11 Month Change0%
3 Month Changen/a
1 Year Change32.54%
33 Year Change8.73%
5 Year Changen/a
Change since IPO97.37%

Recent News & Updates

Recent updates

Shareholder Returns

H1OL34BR Medical EquipmentBR Market
7D0%-1.8%-0.06%
1Y32.5%16.1%-1.6%

Return vs Industry: H1OL34 exceeded the BR Medical Equipment industry which returned 26.3% over the past year.

Return vs Market: H1OL34 exceeded the BR Market which returned 9.5% over the past year.

Price Volatility

Is H1OL34's price volatile compared to industry and market?
H1OL34 volatility
H1OL34 Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.1%
Market Average Movement4.5%
10% most volatile stocks in BR Market8.5%
10% least volatile stocks in BR Market2.3%

Stable Share Price: H1OL34's share price has been volatile over the past 3 months compared to the BR market.

Volatility Over Time: Insufficient data to determine H1OL34's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19856,990Steve MacMillanwww.hologic.com

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth.

Hologic, Inc. Fundamentals Summary

How do Hologic's earnings and revenue compare to its market cap?
H1OL34 fundamental statistics
Market capR$107.13b
Earnings (TTM)R$4.00b
Revenue (TTM)R$22.75b

26.8x

P/E Ratio

4.7x

P/S Ratio

Is H1OL34 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
H1OL34 income statement (TTM)
RevenueUS$3.99b
Cost of RevenueUS$1.57b
Gross ProfitUS$2.42b
Other ExpensesUS$1.71b
EarningsUS$701.50m

Last Reported Earnings

Jun 29, 2024

Next Earnings Date

Nov 04, 2024

Earnings per share (EPS)3.02
Gross Margin60.58%
Net Profit Margin17.59%
Debt/Equity Ratio51.4%

How did H1OL34 perform over the long term?

See historical performance and comparison